Trial Profile
Phase I/II trial investigating CUDC 101 in patients with non-small cell lung cancer
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 06 May 2010
Price :
$35
*
At a glance
- Drugs CUDC 101 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Curis
- 06 May 2010 New trial record